royalty payments

Apogee bags $1.3B royalty funding deal to advance eczema hopeful

Apogee has secured a promise of up to $1.3 billion from Blackstone Life Sciences as the biotech gears up to take its anti-IL-13 antibody into phase 3.

James Waldron May 27, 2026 8:57am

Metallic arrow symbols which are illuminated by blue and magenta lights merge on blue and magenta b

Fierce Pharma

Ligand lays out $739M for royalty aggregator compatriot Xoma

Apr 27, 2026 10:19am

Teva's $400M Blackstone deal to fund Sanofi-partnered IBD drug

Mar 4, 2026 3:07am

Candel glows with $100M RTW deal to fund cancer drug launch

Feb 20, 2026 4:04am

Royalty bestows Zenas with $300M for autoimmune approval push

Sep 2, 2025 11:07am

RegenXBio sells $250M of paydays for Zolgensma, other therapies

May 20, 2025 7:15am